Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 293
Filter
1.
Arq. bras. neurocir ; 41(1): 85-89, 07/03/2022.
Article in English | LILACS | ID: biblio-1362092

ABSTRACT

Introduction Mucoepidermoid carcinoma (MEC) is a tumor originated from the epitheliumof the glandular excretory ducts and has highly variable biological potential. It is the most prevalent cancer of the salivary glands. The present report aims to describe a case of nasal mucoepidermoid carcinoma that developed after adjuvant radiotherapy (RT) treatment of a recurrent pituitary macroadenoma. Case Report Male patient, 62 years old, presented with recurrent nasal epistaxis on the right, associated with intense pulsatile headache, visual analogical scale (VAS) 10/10, with improvement only with the use of opioids andmorphine. After undergoing oncological screening and study by imaging exams, the presence of an expansive seal lesion with suprasellar extension was seen, involving the medial wall of the cavernous segment of the right carotid artery and the anterior cerebral artery, as well as the presence of a new expansive lesion in the right nasal cavity, with ethmoid bone invasion superiorly and medial orbit wall invasion laterally, compressing the ipsilateral optic nerve canal. Discussion Sinonasal neoplasms represent a small portion of all malignancies of the upper aerodigestive tract, accounting for<5% of these neoplasms. The development of MEC involves risk factors such as occupational issues, history of trauma and surgery involving the nasal area, and radiation exposure, as in previous RT. Conclusion Mucoepidermoid carcinoma is an uncommon neoplasia and can be associated with RT treatment, as used in cases of recurrent pituitary macroadenoma. In general, surgical resection to obtain free margins of neoplastic tissue is the aimed treatment, seeking better prognosis.


Subject(s)
Humans , Male , Middle Aged , Pituitary Neoplasms/radiotherapy , Nose Neoplasms/surgery , Carcinoma, Mucoepidermoid/surgery , Nasal Cavity/surgery , Recurrence , Nose Neoplasms/pathology , Carcinoma, Mucoepidermoid/pathology , Carcinoma, Mucoepidermoid/diagnostic imaging , Nasal Cavity/pathology
2.
Article in Chinese | WPRIM | ID: wpr-936156

ABSTRACT

OBJECTIVE@#To investigate the clinicopathological characteristics of micro and mini parotid gland tumors and to provide reference for their clinical diagnosis and treatment.@*METHODS@#Patients with parotid gland tumors treated in the Department of Oral and Maxillofacial Surgery, Peking University School and Hospital of Stomatology from December 2012 to April 2020 were selected. Relevant clinical data of the patients with tumor diameter ≤20 mm detected by preoperative CT were collected to analyze the clinicopathological characteristics and prognosis of micro and mini parotid gland tumors. And the collected data were divided into two groups with diameter 11-20 mm and diameter ≤10 mm according to tumor diameter measured by preoperative CT. The clinicopathological differences between the two groups were statistically analyzed.@*RESULTS@#A total of 2 067 patients with primary epithelial parotid gland tumors were collected, and 685 patients with tumor diameter ≤20 mm were examined by CT, accounting for 33.1%. The ratio of male to female patients with micro and mini parotid gland tumors was 1 ∶1.93, the average age was (45.3±13.8) years (12-83 years), and the median course of disease was 12 months (1 week to 30 years). Among them, 635 cases (92.7%) were benign tumors, 50 cases (7.3%) were malignant tumors, and the ratio of benign to malignant was 12.7 ∶1. The most common benign tumor was pleomorphic adenoma, and the most common malignant tumor was mucoepidermoid carcinoma. The micro and mini parotid gland tumors were divided into 11-20 mm group (n=611) and ≤10 mm group (n=74), the clinical characteristics comparison of the two groups of gender ratio, average age, course of di-sease had no statistical difference (P>0.05). In the 11-20 mm diameter group, the percentage of benign and malignant tumor was 92.8% (567/611) and 7.2% (44/611) respectively, and the ratio of benign to malignant tumors was 12.9 ∶1. In the ≤10 mm diameter group, the percentage of benign and malignant tumor was 91.9% (68/74) and 8.1% (6/74) respectively, and the ratio of benign to malignant tumors was 11.3 ∶1. There was no significant difference between the two groups (P>0.05). Fifty patients with malignant tumor were followed up for the median follow-up period of 39.5 months (1-91 months). Local recurrence occurred in 2 patients with one death. The overall 2-year survival rate was 93.7% and the 5-year survival rate was 89.3%.@*CONCLUSION@#The majority of micro and mini parotid gland tumors was benign lesion. There was a good prognosis for micro and mini parotid gland carcinoma. Early surgical treatment was recommended for micro and mini parotid gland tumors.


Subject(s)
Adenoma, Pleomorphic/surgery , Adult , Carcinoma, Mucoepidermoid/pathology , Female , Humans , Male , Middle Aged , Parotid Gland , Parotid Neoplasms/surgery , Retrospective Studies
3.
Braz. j. otorhinolaryngol. (Impr.) ; 87(2): 171-177, mar.-abr. 2021. tab, graf
Article in English, Portuguese | LILACS | ID: biblio-1249353

ABSTRACT

Resumo Introdução: Tumores de glândulas salivares são um grupo diversificado de lesões, com várias origens e comportamentos extremamente diferentes, resultam em distintos desfechos para os pacientes. Portanto, a necessidade de descobrir novos marcadores com a capacidade de predizer o comportamento de neoplasias de glândulas salivares benignas e malignas é crucial. O syndecan-1 é uma proteína da superfície celular com papéis significativos em vários aspectos da função tumoral. Sua expressão nas neoplasias das glândulas salivares, especialmente seu componente estromal, ainda não foi investigada. Objetivos: Avaliar a imunopositividade do syndecan-1 nos componentes epiteliais e estromais das neoplasias de glândulas salivares e compará-la entre os subtipos benigno e maligno, além de avaliar sua correlação com os parâmetros clínico-patológicos. Método: Foram corados 133 tumores de glândulas salivares imuno-histoquimicamente com syndecan-1 e a intensidade e porcentagem dessa proteína foram determinadas, comparadas entre as lesões e correlacionadas com fatores clínico-patológicos. Resultados: A análise estatística das lesões com tamanho amostral suficiente mostrou diferenças significantes em porcentagem e intensidade entre os componentes epiteliais e estromais de todos os tumores (p < 0,05). As comparações pareadas demonstraram uma porcentagem de coloração significantemente maior das células epiteliais (p = 0,02) no tumor de Warthin em comparação com o adenoma pleomórfico e o carcinoma adenoide cístico. Da mesma forma, foram observadas intensidades de coloração e/ou percentagens significantemente maiores no carcinoma mucoepidermoide e no carcinoma adenoide cístico em comparação ao adenoma pleomórfico e ao tumor de Warthin (p < 0,05). Dos fatores clinico-patológicos, houve apenas uma correlação negativa significante entre o percentual estromal de carcinoma mucoepidermoide e a idade; e uma diferença significante entre a intensidade estromal + porcentagem de carcinoma adenoide cístico e sexo (p < 0,05). Conclusões: De acordo com nossos achados, o syndecan-1 estromal se correlaciona com o comportamento maligno de tumores de glândulas salivares, demonstra uma expressão mais alta, indica um papel para o syndecan-1 na invasão e metástase tumoral.


Subject(s)
Humans , Salivary Gland Neoplasms , Carcinoma, Mucoepidermoid , Carcinoma, Adenoid Cystic , Adenoma, Pleomorphic , Syndecan-1
4.
Braz. oral res. (Online) ; 35: e073, 2021. tab, graf
Article in English | LILACS, BBO | ID: biblio-1278595

ABSTRACT

Abstract The aim of this study was to identify tumor parenchyma cells exhibiting immunohistochemical profile of stem cells by evaluating the immunoreactivity of OCT4 and CD44 in a number of cases of salivary gland neoplasms. The sample consisted of 20 pleomorphic adenomas, 20 mucoepidermoid carcinomas, and 20 adenoid cystic carcinomas located in major and minor salivary glands. The expression of OCT4 and CD44 was evaluated by the percentage of positive cells and the intensity of expression. All studied cases showed positive expression of OCT4 and CD44 and higher values than the control groups. For OCT4, luminal and non-luminal cells were immunostained in the case of pleomorphic adenomas and adenoid cystic carcinomas. Moreover, the immunoreactivity of CD44 was particularly evident in the non-luminal cells of these lesions. In mucoepidermoid carcinomas, there was immunoreactivity for both markers in squamous and intermediate cells and absence of staining in mucous cells. For both markers, a significantly higher immunostaining was verified in neoplasms located in the major salivary glands compared with lesions in minor salivary glands (p<0.001). In the total sample and in minor salivary glands, malignant neoplasms exhibited higher immunoreactivity for OCT4 than pleomorphic adenoma. A significant moderate positive correlation (r = 0.444 and p ≤ 0.001) was found between OCT4 and CD44 immunoexpression in the total sample. The high expression of OCT4 and CD44 may indicate that these proteins play an important role in identifying tumor stem cells.


Subject(s)
Humans , Salivary Gland Neoplasms , Carcinoma, Mucoepidermoid , Carcinoma, Adenoid Cystic , Adenoma, Pleomorphic , Hyaluronan Receptors/genetics , Octamer Transcription Factor-3/economics , Immunohistochemistry
5.
São Paulo; s.n; 2021. 71 p. tab, ilus, graf.
Thesis in Portuguese | LILACS, Inca | ID: biblio-1353654

ABSTRACT

As glândulas salivares são estruturas formadas por um sistema de ductos e ácinos responsáveis por secretar saliva. Apesar de raros, os tumores de glândulas salivares compreendem um grupo heterogêneo de lesões, apresentando diferentes características histológicas, sendo de difícil classificação e comportamento clínico diverso. A identificação de novos marcadores moleculares tem sido alvo de pesquisas para melhor compreensão e classificação dessas neoplasias, visto que a avaliação da expressão gênica e suas vias envolvidas permite identificar genes associados à regulação que modula o desenvolvimento neoplásico. Assim, novos achados podem direcionar a aplicação de novas técnicas para o diagnóstico, prognóstico e tratamento terapêutico. Contudo, pouco se sabe sobre a via de sinalização TGFß em neoplasias mais comuns em glândulas salivares, como: Adenoma Pleomórfico (AP), Carcinoma Mucoepidermoide (CME) e Carcinoma Adenoide Cístico (CAC). Diante disso, torna-se necessário ampliar a pesquisa de genes associados para a determinação de um painel de marcadores e, deste modo, fornecer informações que possam contribuir com o diagnóstico dessas neoplasias. O objetivo desse trabalho foi avaliar a expressão gênica relacionada à via de sinalização TGFß por meio da técnica de RT-PCR em tempo real (qPCR) destacando os marcadores TGFß1, ITGB6, SMAD2, SMAD4, FBN1, LTBP1 e c-MYC. Para tanto, foram selecionadas 13 amostras de AP, 17 de CME e 13 de CAC, além de 10 amostras de glândulas salivares não neoplásicas provenientes de cirurgias realizadas no A.C.Camargo Cancer Center no período do ano 2000 a 2015 e fornecidas pelo Biobanco de Tumores. Os resultados indicam que em pacientes com AP há aumento da expressão dos genes TGFß1, LTPB1, c-MYC e FBN1, enquanto a expressão de SMAD2 diminui quando comparados às amostras não neoplásicas. Em pacientes com CME, foi observada expressão aumentada dos genes TGFß1, ITGB6, FBN1 e c-MYC enquanto a expressão dos genes SMAD2 e SMAD4 diminui ao serem comparados às amostras não neoplásicas. Nos pacientes com CAC, foi observada expressão aumentada em quase todos os genes avaliados. Na análise de clusterização hierárquica não foi possível classificar nas diferentes neoplasias de glândula salivar. Para a validação dos resultados de expressão gênica foi realizada uma meta-análise utilizando dados da literatura, sendo possível observar concordância nos valores de expressão dos genes ITGB6, LTBP1 e TGFß1 em amostras de CME e dos genes FBN1, ITGB6, LTBP1, c-MYC, SMAD2 e SMAD4 nas amostras de CAC. Comparando-se a expressão dos genes entre os três tipos de neoplasias estudados, foi observado aumento de expressão dos genes c-MYC, SMAD2 e SMAD4 nos casos de CAC e aumento da expressão do gene ITGB6 nos casos de CME. A análise de sobrevida demonstrou que, em pacientes com Carcinoma Mucoepidermoide foi observado que a ausência de linfonodo comprometido e ausência de recidiva estão associadas a melhor probabilidade de sobrevida global em 5 anos. Nossos resultados sugerem que a expressão diminuída dos genes SMAD2 e SMAD4 parece não interferir na regulação transcricional de c-MYC, especialmente no AP e CME. Considerando os genes ITGB6, TGFß1, LTBP1, FBN1 e c-MYC a expressão aumentada parece ser relevante para a regulação da via de sinalização no processo de tumorigênese. Sendo assim, este estudo contribui para um melhor entendimento da via de sinalização TGFß em neoplasias de glândulas salivares, além de fornecer informações para o desenvolvimento de potenciais marcadores biológicos para essas neoplasias.


Salivary glands are structures formed by a system of ducts and acini responsible for secreting saliva. Although rare, salivary gland tumors comprise a heterogeneous group of lesions, presenting different histological features, difficult classification, and diverse clinical behavior. Identification of new molecular markers has been the subject of researchers for better comprehension and classification of these tumors, since gene expression evaluation and their signaling pathways allow the identification of genes associated with regulation that modulated tumor development. Therefore, new findings can direct the application of new technologies for diagnosis, prognosis, and therapeutic treatment. However, little is known about the TGFß signaling pathway in the most common salivary gland tumors, such as: Pleomorphic adenoma (PA), mucoepidermoid carcinoma (MEC), and adenoid cystic carcinoma (ACC). In addition, it is necessary to expand research of genes and associated genes for determining a panel of markers and, thus, provide information that could be contribute with the diagnostic of these neoplasms. The aim of this study is to evaluate the expression of genes associated with the TGFß signaling pathway by real-time RT-PCR (qPCR) highlighting the markers TGFß1, ITGB6, SMAD2, SMAD4, FBN1, LTBP1, and c-MYC. For this purpose, 13 PA samples, 17 MEC samples, 13 ACC samples, and histologically normal salivary glands samples were selected from surgeries performed at A.C.Camargo Cancer Center between 2000 and 2015. These samples were provided by Tumor Biobank. The results indicate that PA patients presented an increased TGFß1, LTPB1, c-MYC, and FBN1 gene expression whereas SMAD2 expression was decreased when compared to the normal samples. In MEC patients, increased expression of TGFß1, ITGB6, FBN1, and c-MYC genes was observed whereas SMAD2 and SMAD4 genes presented decreased expression. In ACC patients, increased expression in almost all genes was observed. In hierarchical clustering analysis it was not possible to classify the different salivary gland tumors. For the validation of the gene expression results it was carried out a meta-analysis using the literature date, being possible to observe an agreement in the expression values of the genes ITGB6, LTBP1 and TGFß1 in MEC samples and FBN1, ITGB6, LTBP1, c-MYC, SMAD2 and SMAD4 in ACC samples. Comparing gene expression among the three tumor types studied it was observed higher expression of c-MYC, SMAD2 and SMAD4 genes in ACC cases and higher expression of ITGB6 in MEC cases. Survival analysis demonstrated that, in MEC patients it was observed that absence of affected lymph nodes and absence of recurrence are associated with better overall survival in 5 years. Our results suggest that the decreased expression of SMAD2 and SMAD4 genes seems not to interfere with the transcriptional regulation of c-MYC, especially in PA and MEC. Considering ITGB6, TGFß1, LTBP1, FBN1 and c-MYC increased gene expression appears to be relevant for the regulation of the signaling pathway in tumorigenic process. Thus, this study contributes to a better understanding of TGFß signaling pathway in salivary gland tumors, apart from supplying information in development of potential biomarkers for these tumors.


Subject(s)
Humans , Male , Female , Salivary Gland Neoplasms , Carcinoma, Mucoepidermoid , Carcinoma, Adenoid Cystic , Adenoma, Pleomorphic , Gene Expression Profiling , Transforming Growth Factor beta1
6.
Rev. Asoc. Odontol. Argent ; 108(2): 75-79, mayo-ago. 2020. ilus
Article in Spanish | LILACS | ID: biblio-1121460

ABSTRACT

Objetivo: Describir la técnica de reconstrucción oral con colgajo de músculo temporal por resección de lesión oncológica. Caso clínico: Un paciente de sexo masculino, de 70 años de edad, fue derivado al Hospital Sirio Libanés desde la Facultad de Odontología de la Universidad de Buenos Aires con diagnóstico de carcinoma mucoepidermoide de siete meses de evolución, ubicado en el reborde alveolar del maxilar superior izquierdo, a nivel de las piezas dentarias 25 a 28. Se realizó la resección del tumor bajo anestesia general y la consiguiente reconstrucción del lecho mediante la técnica de reconstrucción oral con colgajo de músculo temporal. Conclusión: El colgajo temporomiofascial resultó ser versátil para la reconstrucción maxilofacial en lo que respecta a la proximidad, el tamaño, la fiabilidad de la vascularización y la facilidad de la técnica (AU)


Aim: To describe the temporalis myofacial flap technique for reconstruction in the maxillofacial region following oral cancer resection. Clinical case: A 70-year-old male patient was referred to the Sirio Libanés Hospital from the Dental School, University of Buenos Aires with a diagnosis of mucoepidermoid carcinoma with 7 months of evolution located in the alveolar ridge of the left upper jaw, at the level of teeth 25 to 28. The tumor was resected under general anesthesia and a rotational flap of the temporalis muscle was used for the reconstruction of the area. Conclusion: The temporalis flap was a versatile option for the reconstruction of maxillofacial defects due to its proximity to the oral cavity, the reliable vascularity and minor donor site morbidity (AU)


Subject(s)
Humans , Male , Aged , Temporal Muscle , Maxillary Neoplasms/surgery , Carcinoma, Mucoepidermoid/surgery , Reconstructive Surgical Procedures/methods , Myocutaneous Flap , Argentina , Schools, Dental , Dental Service, Hospital
7.
Autops. Case Rep ; 9(4): e2019122, Oct.-Dec. 2019. ilus, tab
Article in English | LILACS | ID: biblio-1024306

ABSTRACT

Mucoepidermoid carcinoma (MEC) is the most common malignant salivary gland tumor. Although the parotid gland is the most common site of involvement, other major salivary glands and the minor salivary glands­most commonly of the palate­also can be involved. The management of mucoepidermoid carcinoma depends on the grade of the tumor and the adequacy of resection. We present the case of a 56-year-old female presenting a painless progressive cheek mass over 2 months. Imaging and fine-needle aspiration cytology provided the diagnosis of Mucoepidermoid carcinoma. A superficial parotidectomy was done, and the histopathology revealed a predominantly cystic tumor with a bilayered epithelium of oncocytic and basal cells. Moderate nuclear pleomorphism with infiltration of atypical squamous cells in few glandular cysts was seen. Special staining revealed the presence of intracellular mucin. A diagnosis of Warthin-like variant of MEC was made, based on these findings. After the surgical procedures, the patient is disease-free at 8 months of follow-up. The Warthin-like variant is a rare variant of MEC with fewer than 10 cases described in the English literature. Various differential diagnoses include the malignant transformation of Wartin tumor (WT), squamous metaplasia of WT, and metastasis from a distant primary. We emphasize the role of routine microscopy in identifying rare variants of common malignancies. Even though translocation studies are helpful in diagnosis, the typical histopathological findings should confirm it.


Subject(s)
Humans , Female , Middle Aged , Parotid Neoplasms/pathology , Carcinoma, Mucoepidermoid/pathology , Carcinoma, Mucoepidermoid/surgery , Carcinoma, Mucoepidermoid/therapy
8.
Rev. cuba. cir ; 58(2): e755, mar.-jun. 2019. tab, graf
Article in Spanish | LILACS | ID: biblio-1093157

ABSTRACT

RESUMEN Introducción: Las neoplasias malignas de glándulas salivales se ubican entre las primeras diez localizaciones de incidencia oncológica. Objetivo: Describir el comportamiento epidemiológico-clínico-terapéutico de los tumores malignos de glándulas salivales en pacientes mayores de 15 años en la provincia de Sancti Spiritus entre 2012 y 2015. Métodos: Se realizó un estudio observacional, descriptivo, transversal. La muestra estuvo constituida por 39 pacientes mayores de 15 años, con neoplasias en glándulas salivales que acudieron al servicio de Cirugía Maxilofacial entre el 1 de enero de 2012 y el 31 de diciembre de 2015. Resultados: Predominó el sexo masculino y el rango de edad comprendido entre 45-64 años. Los municipios con mayor número de pacientes fueron Sancti Spiritus y Cabaiguán. El 23,1 por ciento de los obreros están expuestos a los rayos solares y sustancias químicas. Los parámetros clínicos más frecuentes fueron el aumento de volumen, las molestias, el dolor en la región. La glándula parótida fue el sitio anatómico de aparición más frecuente y el carcinoma mucoepidermoide la más recurrente de las neoplasias malignas de glándulas salivales. La supervivencia global a los dos años fue de 84,1 por ciento. Conclusiones: Las neoplasias malignas de glándulas salivales constituyen un problema de salud en el centro del país. Más de la mitad de los casos se diagnostican en etapas avanzadas debido, en parte, a la procedencia rural (zonas de difícil acceso) de gran parte de la muestra. Las cifras de supervivencia se encuentran acorde a parámetros internacionales(AU)


ABSTRACT Introduction: Malignant neoplasms in the salivary glands are among the first ten locations of cancer incidence. Objective: To describe the epidemiological, clinical and therapeutic behavior of malignant salivary gland tumors in patients older than 15 years in Sancti Spiritus Province between 2012 and 2105. Methods: An observational, descriptive, cross-sectional study was carried out. The sample consisted of 39 patients older than 15 years, with salivary gland neoplasms and who attended the maxillofacial surgery service between January 1st, 2012 and December 31st, 2015. Results: The male sex and the age range between 45-64 years predominated. The municipalities with the highest number of patients were Sancti Spiritus and Cabaiguán. 23.1 percent of workers are exposed to sunlight and chemicals. The most frequent clinical parameters were volume increase, discomfort, localized pain. The parotid gland was the most frequent anatomical onset site and the mucoepidermoid carcinoma was the most recurrent of the malignant neoplasms in the salivary glands. The two-year overall survival was 84.1 percent. Conclusions: Malignant neoplasms of salivary glands constitute a health concern in the central region of the country. More than half of the cases are diagnosed in advanced stages due, in part, to the rural origin (hard-to-reach areas) of much of the sample. Survival rates are coincident with international parameters(AU)


Subject(s)
Humans , Male , Adult , Middle Aged , Salivary Gland Neoplasms/diagnostic imaging , Carcinoma, Mucoepidermoid/pathology , Neoplasms/epidemiology , Salivary Gland Neoplasms/drug therapy , Epidemiology, Descriptive , Cross-Sectional Studies , Observational Study
9.
Braz. j. otorhinolaryngol. (Impr.) ; 85(2): 144-149, Mar.-Apr. 2019. tab, graf
Article in English | LILACS | ID: biblio-1001554

ABSTRACT

Abstract Introduction: Cell division cycle-7 protein is a serine/threonine kinase that has a basic role in cell cycle regulation and is a potential prognostic or therapeutic target in some human cancers. Objectives: This study investigated the expression of cell division cycle-7 protein in benign and malignant salivary gland tumors and also its correlation with clinicopathologic factors. Methods: Immunohistochemical expression of cell division cycle-7 was evaluated in 46 cases, including 15 adenoid cystic carcinoma, 12 mucoepidermoid carcinoma, 14 pleomorphic adenoma, and 5 normal salivary glands. Cell division cycle-7 expression rate and intensity were compared statistically. Results: The protein was expressed in almost all tumors. The intensity and mean of cell division cycle-7 expression were higher in malignant tumors in comparison with pleomorphic adenomas (p = 0.000). The protein expression was correlated with tumor grades (p = 0.000). Conclusions: The present study demonstrated cell division cycle-7 overexpression in malignant salivary gland tumors in comparison with pleomorphic adenomas, and also a correlation with tumor differentiation. Therefore, this protein might be a potential prognostic and therapeutic target for salivary gland tumors.


Resumo Introdução: A cell division cycle-7 é uma serina/treonina quinase que tem um papel básico na regulação do ciclo celular e é um potencial marcador prognóstico ou terapêutico em alguns tipos de câncer humano. Objetivos: Este estudo investigou a expressão de cell division cycle-7 em tumores de glândulas salivares benignos e malignos e também sua correlação com fatores clínico-patológicos. Método: A expressão imuno-histoquímica de cell division cycle-7 foi avaliada em 46 casos, incluindo 15 carcinomas adenoide císticos, 12 carcinomas mucoepidermoides, 14 adenomas pleomórficos e 5 glândulas salivares normais. A taxa de expressão e a intensidade da proteína cell division cycle-7 foram comparadas estatisticamente. Resultados: A proteína foi expressa em quase todos os tumores. A intensidade e a média da expressão de cell division cycle-7 foram maiores em tumores malignos em comparação com adenoma pleomórfico (p = 0,000). A expressão da proteína foi correlacionada com os graus do tumor (p = 0,000). Conclusões: O presente estudo demonstrou a superexpressão de cell division cycle-7 em tumores malignos de glândulas salivares quando comparada com o adenoma pleomórfico, além de uma correlação com a diferenciação de tumores. Portanto, essa proteína pode ser um potencial marcador prognóstico e terapêutico para tumores de glândulas salivares.


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Aged , Salivary Gland Neoplasms/pathology , Protein Serine-Threonine Kinases/analysis , Carcinoma, Mucoepidermoid/pathology , Carcinoma, Adenoid Cystic/pathology , Adenoma, Pleomorphic/pathology , Cell Cycle Proteins/analysis , Prognosis , Reference Values , Immunohistochemistry , Biomarkers, Tumor/analysis , Case-Control Studies , Cell Differentiation , Cross-Sectional Studies , Retrospective Studies
10.
Article in Korean | WPRIM | ID: wpr-787193

ABSTRACT

Mucoepidermoid carcinoma is a malignant tumor that occurs mainly in the salivary glands of adults and children, but rarely in the esophagus. A surgical resection is the primary treatment for mucoepidermal carcinoma, and the prognosis has been reported to be poor. A 61-year-old man was diagnosed with an esophageal nodule in upper gastrointestinal endoscopy for the purpose of a medical examination without any special symptoms and an endoscopic resection was performed for an accurate diagnosis. An endoscopic mucosal resection was performed using a band ligation for a complete resection and continuous follow-up with no evidence of recurrence or metastasis. The unknown prognosis of endoscopic resection makes it necessary to follow the patient carefully.


Subject(s)
Adult , Carcinoma, Mucoepidermoid , Child , Diagnosis , Endoscopy, Gastrointestinal , Esophagus , Follow-Up Studies , Humans , Ligation , Middle Aged , Neoplasm Metastasis , Prognosis , Recurrence , Salivary Glands
11.
Article in Korean | WPRIM | ID: wpr-761545

ABSTRACT

Mucoepidermoid carcinoma is a malignant tumor that occurs mainly in the salivary glands of adults and children, but rarely in the esophagus. A surgical resection is the primary treatment for mucoepidermal carcinoma, and the prognosis has been reported to be poor. A 61-year-old man was diagnosed with an esophageal nodule in upper gastrointestinal endoscopy for the purpose of a medical examination without any special symptoms and an endoscopic resection was performed for an accurate diagnosis. An endoscopic mucosal resection was performed using a band ligation for a complete resection and continuous follow-up with no evidence of recurrence or metastasis. The unknown prognosis of endoscopic resection makes it necessary to follow the patient carefully.


Subject(s)
Adult , Carcinoma, Mucoepidermoid , Child , Diagnosis , Endoscopy, Gastrointestinal , Esophagus , Follow-Up Studies , Humans , Ligation , Middle Aged , Neoplasm Metastasis , Prognosis , Recurrence , Salivary Glands
12.
Article in English | WPRIM | ID: wpr-760084

ABSTRACT

Carcinosarcomas, also known as true malignant mixed tumors, are rare tumors of the salivary gland and are composed of both malignant epithelial and malignant mesenchymal elements. They may occur in pre-existing pleomorphic adenomas or arise de novo. Here we report the first case of carcinosarcoma of the parotid gland composed of mucoepidermoid carcinoma and osteosarcoma. The tumor had originated from the parotid gland and extended into the parapharyngeal space. To the best of our knowledge, there have been no reports on mucoepidermoid carcinoma mixed with osteosarcoma ex pleomorphic adenoma in the parotid gland.


Subject(s)
Adenoma, Pleomorphic , Carcinoma, Mucoepidermoid , Carcinosarcoma , Mixed Tumor, Malignant , Osteosarcoma , Parotid Gland , Salivary Glands
13.
Rev. chil. enferm. respir ; 34(2): 118-121, ago. 2018. graf
Article in Spanish | LILACS | ID: biblio-959416

ABSTRACT

Resumen El carcinoma mucoepidermoide bronquial es una neoplasia infrecuente, representando el 0,1 a 0,2% de los tumores malignos primarios del pulmón. En general tiene un buen pronóstico, sin embargo, existe un subtipo de alto grado de pronóstico más ominoso. En este artículo se presentan dos casos clínicos de carcinoma mucoepidermoide bronquial de bajo grado, enfocado en su diagnóstico y manejo quirúrgico.


ABSTRACT Bronchopulmonary mucoepidermoid carcinoma is an uncommon neoplasm, accounting for 0.1 to 0.2% of primary malignant tumors of the lung. In general it has a good prognosis, however there is a subtype of high grade of more ominous prognosis. In this paper we present two clinical cases of low grade pulmonary mucoepidermoid carcinoma, focused on their diagnosis and surgical management.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Bronchial Neoplasms/surgery , Bronchial Neoplasms/diagnosis , Carcinoma, Mucoepidermoid/surgery , Carcinoma, Mucoepidermoid/diagnosis , Prognosis , Thorax/diagnostic imaging , Bronchoscopy/instrumentation , Tomography, X-Ray Computed , Microscopy/instrumentation
14.
Rev. Fac. Odontol. (B.Aires) ; 33(74): 40-43, ene.-jun. 2018. ilus
Article in Spanish | LILACS | ID: biblio-969729

ABSTRACT

El carcinoma mucoepidermoide intraóseo (CMEI) es una neoplasia maligna de los maxilares muy poco frecuente. Es idéntica en casi todos sus aspectos al carcinoma mucoepidermoide de glándulas salivales pero, a diferencia de éste, asienta completamente en tejido óseo. Presentamos un caso clínico de CMEI en una paciente de 66 años de edad. Se describen las características clínicas, radiográficas e histopatológicas, tratamiento y evolución. Además se llevó a cabo una revisión de la literatura en PubMed acerca de CMEI de mandíbula publicada en los últimos diez años (AU)


Intraosseous mucoepidermoid carcinoma (IMCC) is an infrequent malignant tumor of the jaws that is identical in most respects to the mucoepidermoid carcinoma of salivary glands but arises entirely within the bone. We report a case of IMEC in a 66-year old woman. We describe the clinical, radiographic and histopathologic aspects as well as the treatment and follow-up. Additionally, we performed a literature review on PubMed regarding IMEC of the mandible published in last ten years (AU)


Subject(s)
Humans , Female , Aged , Mandibular Neoplasms , Carcinoma, Mucoepidermoid , Oral Surgical Procedures , Argentina , Surgical Flaps , Follow-Up Studies , Dental Service, Hospital
15.
Article in Korean | WPRIM | ID: wpr-713965

ABSTRACT

This report is a case of 38-year old female patient who had a chief complaint about having pronounciation disorder after going under mass excision due to mucoepidermoid carcinoma. She was referred to department of prosthodontics, Yonsei university. Palatal lift prosthesis was fabricated which was then relined with tissue conditioner. Evaluations on phonetics and swallowing were done and improvements were shown. Tissue conditioner was replaced with heat polymerizing resin and the patient was satisfied with the results of treatment.


Subject(s)
Carcinoma, Mucoepidermoid , Deglutition , Female , Hot Temperature , Humans , Phonetics , Polymers , Prostheses and Implants , Prosthodontics
16.
Article in English | WPRIM | ID: wpr-717483

ABSTRACT

No abstract available.


Subject(s)
Carcinoma, Mucoepidermoid , Lacrimal Apparatus
17.
Radiation Oncology Journal ; : 317-324, 2018.
Article in English | WPRIM | ID: wpr-741959

ABSTRACT

PURPOSE: This study aimed to evaluate the long-term survival outcomes and prognostic factors that affect the clinical outcomes of patients who underwent surgery and postoperative radiotherapy for major salivary gland mucoepidermoid carcinoma (MEC). MATERIALS AND METHODS: We retrospectively reviewed the clinical data of 44 patients who underwent surgery followed by radiotherapy for primary MEC of the major salivary glands between 1991 and 2014. The median follow-up period was 9.8 years (range, 0.8 to 23.8 years). RESULTS: The overall outcomes at 5 and 10 years were 81.5% and 78.0% for overall survival (OS), 86.2% and 83.4% for disease-free survival, 90.6% and 87.6% for locoregional recurrence-free survival, and both 90.5% for distant metastasis-free survival (DMFS). Histologic grade was the only independent predictor of OS (low vs. intermediate vs. high; hazard ratio = 3.699; p = 0.041) in multivariate analysis. A poorer survival was observed among patients with high-grade tumors compared with those with non-high-grade tumors (5-year OS, 37.5% vs. 91.7%, p < 0.001; 5-year DMFS, 46.9% vs. 100%, p < 0.001). CONCLUSION: Surgery and postoperative radiotherapy resulted in excellent survival outcomes for patients with major salivary gland MEC. However, high-grade tumors contributed to poor DMFS and OS. Additional aggressive strategies for improving survival outcomes should be developed for high-grade MEC.


Subject(s)
Carcinoma, Mucoepidermoid , Disease-Free Survival , Follow-Up Studies , Humans , Multivariate Analysis , Radiotherapy , Retrospective Studies , Salivary Gland Neoplasms , Salivary Glands
18.
São Paulo; s.n; 20180000. 117 p.
Thesis in Portuguese | LILACS, BBO | ID: biblio-1005349

ABSTRACT

O carcinoma mucoepidermóide (CME) é o tumor mais comum entre as neoplasias malignas de glândula salivar. Recentemente, uma rara população de células com características de multipotência, autorrenovação e potencial tumorigênico, denominadas como células tronco tumorais (CTT), foi descrita no CME. As CTT são resistentes as terapias atuais, e têm sido consideradas responsáveis pela recorrência e metástase, levando a um pior prognóstico para o paciente. A descoberta de que as CTT do CME superexpressam componentes da via de sinalização mTOR, levantou a hipótese que os pacientes poderiam ser beneficiados com o uso inibidores de mTOR como terapia para eliminação das CTT. O objetivo desse estudo foi avaliar o potencial uso de inibidores de mTOR como terapia para o CME com foco em CTT, assim como, investigar o funcionamento da via de sinalização mTOR e os efeitos moleculares do tratamento com inibidores dessa via nas CTT do CME. Foi realizada imuno-histoquímica para p-mTOR e p-S6K-1 em casos de pacientes diagnosticados com CME, os resultados foram correlacionados com os dados clínicos dos pacientes e também foi realizada dupla marcação por imunofluorescência para ALDH/p-mTOR. Estudos in vitro foram realizados em 3 linhagens de CME (UM-HMC-1, -3A, -3B) e com inibidores da via de sinalização mTOR. Após exposição aos inibidores, realizou-se ensaios de western blot (proteínas da via mTOR e BMI-1), citometria de fluxo para ALDH/CD44; salisfera; e apoptose, esse último comparando com quimioterápicos utilizados atualmente. Adicionalmente, foi utilizado o silenciamento genético de mTOR para confirmar os resultados obtidos com inibidores químicos. Por fim, foram realizados ensaios in vivo com as células silenciadas e com o inibidor de mTOR tensirolimo. Os resultados evidenciaram que a via de sinalização mTOR está ativa no CME, é correlacionada com pior prognóstico clínico e está superexpressa nas CTT. O tratamento com inibidores da via mTOR levaram a diminuição da fração de CTT, devido a perda de autorrenovação e apoptose das CTT. A apoptose, junto a diminuição de p-AKT revelada por western blot, sugeriram que esteja ocorrendo inibição de mTORC2 nas CTT, um importante componente na eficácia do tratamento com inibição de mTOR no câncer. Além disso, também houve redução de vasos sanguíneos, nichos das CTT, e diminuição do crescimento tumoral com uso de inibidores ou silenciando mTOR in vivo. Coletivamente, os resultados mostraram que a inibição de mTOR foi capaz de agir nas CTT por mecanismos diretos (indução de apoptose e diminuição da autorrenovação) e indiretamente através da redução de angiogênese, sugerindo que o uso de inibidores de mTOR no tratamento do CME é uma estratégia molecular eficiente para a redução de CTT, e uma potencial terapia adjuvante.


Subject(s)
Tumor Stem Cell Assay , Carcinoma, Mucoepidermoid , Drug Therapy
19.
Rev. chil. cir ; 70(2): 194-198, 2018. ilus
Article in Spanish | LILACS | ID: biblio-990836

ABSTRACT

Resumen: Introducción: Los tumores de glándulas salivales son neoplasias poco frecuentes y representan menos del 5% de todos los tumores de cabeza y cuello. El carcinoma mucoepidermoide representa un 10-15% de todas las neoplasias de las glándulas salivales y aproximadamente un 30% de los tumores malignos salivales. El comportamiento biológico y las manifestaciones clínicas de este tipo de tumores son variables y se correlacionan con el estadio y grado histológico, siendo la presencia de metástasis a distancia un hallazgo inhabitual (en especial, en tumores de grado bajo o intermedio). Caso clínico: Paciente de 65 anos de edad con antecedentes de tabaquismo, a quien se diag nostica carcinoma mucoepidermoide de grado intermedio de glándula submandibular izquierda tratado con cirugía más radioterapia adyuvante, y que presenta progresión metastásica hepática y carcinomatosis peritoneal a los 26 meses de seguimiento.


Abstract: Introduction: Tumors of salivary glands are uncommon and comprise of about 5% of all head and neck tumors. Although constituting less than 15% of all salivary gland tumors, mucoepidermoid carcinoma account for approximately 30% of all malignant salivary gland neoplasms. Commonly these tumours are metastatic to local lymph nodes and distant metastases are rare (especially, in low and intermediate grade tumors). Case report: We report a case of 65 years old man who developed peritoneal carcinomatosis secondary to metastatic dissemination of mucoepidermoid carcinoma of the major salivary glands, which is an uncommon occurrence with intermediate grade tumors.


Subject(s)
Humans , Male , Aged , Peritoneal Neoplasms/secondary , Salivary Gland Neoplasms/pathology , Carcinoma, Mucoepidermoid/secondary , Liver Neoplasms/secondary
20.
Arch. argent. pediatr ; 115(4): 260-264, ago. 2017. ilus
Article in Spanish | LILACS, BINACIS | ID: biblio-887359

ABSTRACT

Los tumores bronquiales son raros en los niños. La mayoría son malignos; el más común es el tumor carcinoide. Con menor frecuencia, se asienta en el árbol traqueobronquial el carcinoma mucoepidermoide. El carcinoma mucoepidermoide representa del 0,1% al 0,2% de los tumores malignos broncopulmonares. Se manifiesta con síntomas de obstrucción de la vía aérea y/o neumonías recurrentes. El diagnóstico precoz y el tratamiento adecuado son de gran importancia en el pronóstico. La broncoscopía con biopsia de la masa endobronquial es el método de elección para confirmar el diagnóstico. El tratamiento consiste en la resección quirúrgica de la lesión. Se presenta a una niña de 11 años con disnea de esfuerzo y tos debidas a un carcinoma mucoepidermoide bronquial de bajo grado de malignidad. Se describen las manifestaciones clínicas, los métodos diagnósticos y el tratamiento de esta rara neoplasia en pediatría.


Bronchial tumors are rare in children. Most of them are malignant, being the carcinoid tumor the most common. Less frequently the mucoepidermoid carcinoma is found in the tracheobronchial tree. Mucoepidermoid carcinoma accounts for 0.1 to 0.2% of all malignant bronchopulmonary tumors. It manifests with symptoms of airway obstruction and/or recurrent pneumonias. Early diagnosis and appropriate treatment are of great importance in the prognosis. Bronchoscopy with biopsy of the endobronchial mass is the method of choice to confirm the diagnosis. Treatment consists of surgical resection of the lesion. We present an 11-year-old girl with dyspnea on exertion and cough due to a low malignant mucoepidermoid carcinoma of the bronchi. We describe the clinical manifestations, the diagnostic methods and the treatment of this rare neoplasia in pediatrics.


Subject(s)
Humans , Female , Child , Bronchial Neoplasms/surgery , Bronchial Neoplasms/diagnosis , Carcinoma, Mucoepidermoid/surgery , Carcinoma, Mucoepidermoid/diagnosis
SELECTION OF CITATIONS
SEARCH DETAIL